Wet age-related macular degeneration.
Melnikova
Irena
I
MedaCorp, a division of Leerink Swann, Boston, Massachusetts 02110, USA. irenam@medacorp.com
D000367:Age Factors; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000145:classification / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D005544:Forecasting; D006801:Humans; D008268:Macular Degeneration / Q000191:economics / Q000209:etiology* / Q000628:therapy*; D040541:Marketing / Q000639:trends; D008875:Middle Aged; D010789:Phototherapy; D000069579:Ranibizumab
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab